Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2839)	6/28/2010 6:39:49 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

BCRX was up th 8.32% with volume of 833,608 >2x its ADV But the stock isn't doing well AHs. bigcharts.marketwatch.com As mentioned. BCRX has 4Qs of better revenues. It was able to trim its losses last Yr. and more significantly on the 1stQ of the current Yr. But the EL for 2010 is around $0.41 vs. $0.35 in 2009 and for 2011 a higher L around $0.75 is still expected. As also mentioned, he ACTAY is $10.13 But there is a good amount of resistance from the $8 to the $8.40 level.<g> I will put a TT at $7.70 while waiting for further Peramivir news.<g> bigcharts.marketwatch.com Bernard